Cyclacel Pharmaceuticals Stock Price Prediction
| CYCC Stock | USD 0.41 0.06 17.14% |
Oversold Vs Overbought
30
Oversold | Overbought |
EPS Estimate Next Quarter (0.40) | EPS Estimate Current Year (1.95) | EPS Estimate Next Year (1.18) | Wall Street Target Price 1 | EPS Estimate Current Quarter (0.55) |
Using Cyclacel Pharmaceuticals hype-based prediction, you can estimate the value of Cyclacel Pharmaceuticals from the perspective of Cyclacel Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cyclacel Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Cyclacel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cyclacel Pharmaceuticals after-hype prediction price | USD 0.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cyclacel |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclacel Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Cyclacel Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cyclacel Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cyclacel Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cyclacel Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Cyclacel Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cyclacel Pharmaceuticals' historical news coverage. Cyclacel Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.02 and 8.40, respectively. We have considered Cyclacel Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cyclacel Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Cyclacel Pharmaceuticals is based on 3 months time horizon.
Cyclacel Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cyclacel Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cyclacel Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cyclacel Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.15 | 7.98 | 0.06 | 0.03 | 8 Events / Month | 14 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.41 | 0.35 | 14.63 |
|
Cyclacel Pharmaceuticals Hype Timeline
Cyclacel Pharmaceuticals is currently traded for 0.41. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.03. Cyclacel is forecasted to decline in value after the next headline, with the price expected to drop to 0.35. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -14.63%, whereas the daily expected return is currently at -1.15%. The volatility of related hype on Cyclacel Pharmaceuticals is about 34630.19%, with the expected price after the next announcement by competition of 0.44. About 18.0% of the company shares are held by institutions such as insurance companies. The book value of Cyclacel Pharmaceuticals was currently reported as 0.57. The company recorded a loss per share of 27.4. Cyclacel Pharmaceuticals last dividend was issued on the 15th of April 2020. The entity had 1:15 split on the 18th of December 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Cyclacel Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Cyclacel Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Cyclacel Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Cyclacel Pharmaceuticals' future price movements. Getting to know how Cyclacel Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cyclacel Pharmaceuticals may potentially react to the hype associated with one of its peers.
Cyclacel Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Cyclacel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cyclacel using various technical indicators. When you analyze Cyclacel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cyclacel Pharmaceuticals Predictive Indicators
The successful prediction of Cyclacel Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cyclacel Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cyclacel Pharmaceuticals based on analysis of Cyclacel Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cyclacel Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cyclacel Pharmaceuticals's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0885 | 0.0929 | Price To Sales Ratio | 6.22 | 5.91 |
Story Coverage note for Cyclacel Pharmaceuticals
The number of cover stories for Cyclacel Pharmaceuticals depends on current market conditions and Cyclacel Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cyclacel Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cyclacel Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cyclacel Pharmaceuticals Short Properties
Cyclacel Pharmaceuticals' future price predictability will typically decrease when Cyclacel Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cyclacel Pharmaceuticals often depends not only on the future outlook of the potential Cyclacel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclacel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 850.8 K | |
| Cash And Short Term Investments | 3.4 M |
Complementary Tools for Cyclacel Stock analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |